1. Home
  2. MLAB vs BOC Comparison

MLAB vs BOC Comparison

Compare MLAB & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • BOC
  • Stock Information
  • Founded
  • MLAB 1982
  • BOC 2009
  • Country
  • MLAB United States
  • BOC United States
  • Employees
  • MLAB N/A
  • BOC N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • BOC
  • Sector
  • MLAB Industrials
  • BOC
  • Exchange
  • MLAB Nasdaq
  • BOC Nasdaq
  • Market Cap
  • MLAB 524.2M
  • BOC 482.8M
  • IPO Year
  • MLAB N/A
  • BOC 2017
  • Fundamental
  • Price
  • MLAB $101.91
  • BOC $14.45
  • Analyst Decision
  • MLAB Hold
  • BOC Buy
  • Analyst Count
  • MLAB 2
  • BOC 2
  • Target Price
  • MLAB $130.00
  • BOC $20.00
  • AVG Volume (30 Days)
  • MLAB 225.6K
  • BOC 164.7K
  • Earning Date
  • MLAB 08-04-2025
  • BOC 08-12-2025
  • Dividend Yield
  • MLAB 0.62%
  • BOC N/A
  • EPS Growth
  • MLAB N/A
  • BOC N/A
  • EPS
  • MLAB N/A
  • BOC 0.03
  • Revenue
  • MLAB $240,978,000.00
  • BOC $110,452,664.00
  • Revenue This Year
  • MLAB $6.28
  • BOC $9.19
  • Revenue Next Year
  • MLAB $5.93
  • BOC $6.50
  • P/E Ratio
  • MLAB N/A
  • BOC $537.02
  • Revenue Growth
  • MLAB 11.47
  • BOC 11.58
  • 52 Week Low
  • MLAB $86.04
  • BOC $12.41
  • 52 Week High
  • MLAB $155.12
  • BOC $16.20
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 53.02
  • BOC 56.59
  • Support Level
  • MLAB $93.57
  • BOC $13.90
  • Resistance Level
  • MLAB $101.11
  • BOC $14.27
  • Average True Range (ATR)
  • MLAB 4.76
  • BOC 0.28
  • MACD
  • MLAB 1.20
  • BOC 0.07
  • Stochastic Oscillator
  • MLAB 97.93
  • BOC 94.87

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a us-based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. They generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: